Potential antitrust deregulation could foster a more favourable environment for ...
Charles River and Akron Bio have announced the integration of the latter’s CSS l...
The FDA has narrowly beaten the European Medicines Agency (EMA) to the most appr...
The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to so...
The Lonza CEO said the company is not under any pressure to exit the Capsules an...
Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug...
IMPACT Therapeutics has received the China NMPA marketing authorisation for Sena...
Imagine a world in which aging cells, once written off as irreversible markers o...
In a world increasingly dominated by high-speed digital engagement and relentles...
Autonomous vehicles (AVs) are poised to revolutionize transportation, promising ...
Scientists at the Gladstone Institutes and the regenerative medicine company San...
Fibrolamellar hepatocellular carcinoma (FLC) remains one of the most enigmatic f...
In an innovative breakthrough, researchers at the Department of Energy’s Oak Rid...
Maital Neta, a distinguished professor of psychology at the University of Nebras...
Solar Wind Dynamics: Understanding the Mechanisms Behind Charged Particle Accele...
Researchers at the Center for Advanced Bioenergy and Bioproducts Innovation (CAB...
